Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neuroblastoma 4Multiple Myeloma 2Vaccinia 1Transplant-Related Hematologic Malignancy 1Recurrence 1Prostatic Neoplasms 1Oligodendroglioma 1Neoplasms 1Medulloblastoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Kidney Neoplasms 1Hodgkin Disease 1Glioma 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Tamoxifen 7Specimen Handling 7exemestane 3Letrozole 3Anastrozole 3Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Biopsy 2ruxolitinib 1poly ICLC 1fezolinetant 1elacestrant 1Testosterone 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Selective Estrogen Receptor Modulators 1Radiotherapy 1Radiation 1Protons 1Proton Therapy 1Omacor 1Neoadjuvant Therapy 1Multicenter Studies as Topic 1Metformin 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Magnetic Resonance Spectroscopy 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × Granulocyte-Macrophage Colony-Stimulating Factor × 90 days × Clear all
NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic

Phase 1 Recruiting
43 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡